Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence.

Authors:
Omer Araz Fadime Sultan Albez Elif Yilmazel Ucar Bugra Kerget Nafiye Yılmaz Metin Akgun

Lung 2017 08 15;195(4):497-502. Epub 2017 Jun 15.

Department of Pulmonary Diseases, Ataturk University School of Medicine, 25240, Erzurum, Turkey.

Purpose: Recurrence is a major clinical problem in patients with pulmonary embolism and can affect mortality. The decision to discontinue treatment is important for recurrence and is based on patients' clinical features as well as certain blood parameters. Our aim in this study was to evaluate whether mean platelet volume (MPV) and platelet distribution width (PDW) have utility as new predictive parameters for recurrence and mortality in pulmonary embolism.

Materials And Methods: A total of 440 patients with pulmonary embolism underwent computed tomography, Doppler ultrasonography, and echocardiography before and at the conclusion of treatment. Thrombocyte count, MPV, PDW, and D-dimer parameters were also evaluated at the same time points.

Results: MPV and PDW were significantly higher in deceased patients (8.8 ± 1.2 fl and 17.4 ± 0.8) compared to surviving patients (7.7 ± 0.9 fl and 17 ± 0.9) (p < 0.0001). Initial MPV and PDW were also significantly higher in patients with recurrence (8.4 ± 0.7 vs 7.6 ± 0.8 fl, p < 0.0001 and 17.3 ± 0.8 vs 16.9 ± 0.9, p = 0.002, respectively) than in patients without recurrence. At the end of treatment, MPV was still higher in patients with recurrence compared to patients without recurrence (8.7 ± 0.5 and 7.5 ± 0.7 fl, respectively, p < 0.0001). MPV values over 8.05 fl at the end of treatment predicted recurrence with 91% sensitivity and 77% specificity.

Conclusion: MPV seems to be an indicator of recurrence in pulmonary embolism and may have utility in the prediction of recurrence. Elevated MPV can also be used to predict mortality in pulmonary embolism.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00408-017-0020-7DOI Listing
August 2017

Publication Analysis

Top Keywords

pulmonary embolism
12
mpv pdw
8
platelet volume
8
patients pulmonary
8
440 patients
4
total 440
4
methods total
4
embolismmaterials methods
4
embolism underwent
4
doppler ultrasonography
4
underwent computed
4
pulmonary embolismmaterials
4
tomography doppler
4
computed tomography
4
recurrence mortality
4
platelet distribution
4
mpv platelet
4
volume mpv
4
evaluate platelet
4
distribution width
4

Altmetric Statistics


Show full details
1 Total Shares
1 Tweets
1 Citations

Similar Publications

Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

Authors:
Xin Zhang Qiyan Cai Xiaohui Wang Ke Liao Changchun Hu Hong Chen

J Thromb Thrombolysis 2021 Mar 5. Epub 2021 Mar 5.

Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Venous thromboembolism (VTE), which is characterized by pulmonary embolism and deep vein thrombosis, has become a serious public concern. Notably, over half of the patients with VTE are over 70 years of age, but elderly patients are at high risk of anti-coagulation and bleeding, which increase with age. Moreover, risk factors and frailty also show a difference between elderly patients and ordinary patients diagnosed with VTE. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Stratifying pulmonary embolism risk in COVID-19 pneumonia in the Emergency Department: the Bergamo Emergency Room pulmonary embolism risk in COVID-19 score - a pilot study.

Authors:
Alessio Marra Federico Zanardi Marina Marchetti Valentina Rosti Eliana Margutti Anna Falanga Roberto Cosentini

Eur J Emerg Med 2021 Apr;28(2):158-161

Emergency Department.

View Article and Full-Text PDF
April 2021
Similar Publications

Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.

Authors:
Robert P Runner David N Shau Christopher A Staley James R Roberson

J Arthroplasty 2021 Feb 2. Epub 2021 Feb 2.

Department of Orthopaedics, Emory University, Atlanta, GA.

Background: The optimum venous thromboembolism (VTE) prophylaxis strategy to minimize risk of VTE and bleeding complications following revision total hip and knee arthroplasty (rTHA/rTKA) is controversial. The purpose of this study is to describe current VTE prophylaxis patterns following revision arthroplasty procedures to determine efficacy, complication rates, and prescribing patterns for different prophylactic strategies.

Methods: The American Board of Orthopedic Surgery Part II (oral) examination case list database was analyzed. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Benefits of early ambulation within 24 h after total knee arthroplasty: a multicenter retrospective cohort study in China.

Authors:
Yi-Ting Lei Jin-Wei Xie Qiang Huang Wei Huang Fu-Xing Pei

Mil Med Res 2021 Mar 5;8(1):17. Epub 2021 Mar 5.

Department of Orthopedics, West China Hospital, Sichuan University, 37# WainanGuoxue Road, Chengdu, 610041, China.

Background: Postoperative care has been evolving since the concept of enhanced recovery after surgery (ERAS) was introduced in China. This study aimed to evaluate the effects of early ambulation within 24 h after unilateral total knee arthroplasty (TKA) on postoperative rehabilitation and costs in a Chinese population.

Methods: This cohort study of patients with knee osteoarthritis who had undergone TKA at 24 large teaching hospitals between January 2014 and November 2016 involved 2687 patients who began ambulating within 24 h (Group A) and 3761 who began ambulating later than 24 h (Group B). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Internal Jugular Vein Thrombosis: Etiology, Symptomatology, Diagnosis and Current Treatment.

Authors:
Alba Scerrati Erica Menegatti Matilde Zamboni Anna Maria Malagoni Mirko Tessari Roberto Galeotti Paolo Zamboni

Diagnostics (Basel) 2021 Feb 23;11(2). Epub 2021 Feb 23.

Vascular Diseases Center, University Hospital of Ferrara, 44121 Ferrara, Italy.

(1) Background: internal jugular vein thrombosis (IJVthr) is a potentially life-threating disease but no comprehensive reviews on etiology, symptomatology, diagnosis and current treatment guidelines are yet available; (2) Methods: we prospectively developed a protocol that defined objectives, search strategy for study identification, criteria for study selection, data extraction, study outcomes, and statistical methodology, according to the PRISMA standard. We performed a computerized search of English-language publications listed in the various electronic databases. We also retrieved relevant reports from other sources, especially by the means of hand search in the Glauco Bassi Library of the University of Ferrara; (3) Results: using the predefined search strategy, we retrieved and screened 1490 titles. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap